Comparative coronary risks of apixaban, rivaroxaban and dabigatran: a meta-analysis and adjusted indirect comparison
2014 ◽
Vol 78
(4)
◽
pp. 707-717
◽
2012 ◽
Vol 60
(17)
◽
pp. B187
2019 ◽
Vol 26
(6)
◽
pp. 1026-1035.e4
◽
Keyword(s):
Keyword(s):
2015 ◽
Vol 41
(3)
◽
pp. 282-294
◽
2012 ◽
Vol 60
(17)
◽
pp. B50
Keyword(s):